Grapefruit Juice
Commercial grapefruit juice (typical 240 mL glass). Same furanocoumarin mechanism as whole fruit; dose-dependent intestinal CYP3A4 inactivation. Confidence: high.
Projected serum levels — 240 mL (≈ 240 mg), as needed (shown daily)
Maintenance schedule: 240 mL (≈ 240 mg) as needed (shown daily) (oral).
Modeled steady state after ~7 days: peak ≈ 0 mg, trough ≈ 0 mg body load. Population-based estimate over 15 days for a reference dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.
Key facts
- Category
- Food
- Route modeled
- Oral
- Model confidence
- inferred
- Common dose
- 240 mL (≈ 240 mg)
- Suggested maximum
- 720 mL/day
- Reference dose range
- 120–720 mL (single dose)
- Suggested cadence
- as needed (shown daily)
Documented interactions
-
contraindicated
Alfuzosin (Uroxatral) + Grapefruit Juice
Grapefruit Juice mechanism_based of CYP3A4 predicted to change Alfuzosin (Uroxatral) AUC by ~10.00x
-
contraindicated
Alprazolam (Xanax) + Grapefruit Juice
Grapefruit Juice mechanism_based of CYP3A4 predicted to change Alprazolam (Xanax) AUC by ~10.00x
-
contraindicated
Amlodipine (Norvasc) + Grapefruit Juice
Grapefruit Juice mechanism_based of CYP3A4 predicted to change Amlodipine (Norvasc) AUC by ~10.00x
-
contraindicated
Anastrozole (Arimidex) + Grapefruit Juice
Grapefruit Juice mechanism_based of CYP3A4 predicted to change Anastrozole (Arimidex) AUC by ~5.14x
-
contraindicated
Astaxanthin + Grapefruit Juice
Grapefruit Juice mechanism_based of CYP3A4 predicted to change Astaxanthin AUC by ~10.00x
-
contraindicated
Atogepant (Qulipta) + Grapefruit Juice
Grapefruit Juice mechanism_based of CYP3A4 predicted to change Atogepant (Qulipta) AUC by ~10.00x
Serum checks 206 modeled interaction pairings for grapefruit juice across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.